about
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countriesNeglected parasitic infections and poverty in the United StatesNeglected parasitic infections in the United States: toxoplasmosisRepurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolyticaUnderstanding Toxoplasmosis in the United States Through "Large Data" AnalysesToxoplasma gondii merozoite gene expression analysis with comparison to the life cycle discloses a unique expression state during enteric developmentToxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis.Toxoplasma gondii in the Food SupplyAvirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondiiFoodborne toxoplasmosis.Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201Epidemiology of ocular toxoplasmosis.Toxoplasmosis: a global threat.Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection.Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infectionOcular toxoplasmosis in Iran: 40 cases analysisFunctional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities.The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.Toxoplasma gondii infection: relationship between seroprevalence and risk factors among primary schoolchildren in the capital areas of Democratic Republic of São Tomé and Príncipe, West Africa.Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological studySeroepidemiology of toxoplasmosis in rural and urban communities from Los Rios Region, Chile.Clinical Features and Risk Factors of Patients with Presumed Ocular ToxoplasmosisPyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase.Ocular Toxoplasmosis: Controversies in Primary and Secondary PreventionDrugs in development for toxoplasmosis: advances, challenges, and current status.Ocular toxoplasmosis I: parasitology, epidemiology and public health.Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.Decline in Ocular Toxoplasmosis over 40 Years at a Tertiary Referral Practice in the United States.Toxoplasma gondii infection: seroprevalence and associated risk factors among primary schoolchildren in Lagos City, Southern Nigeria.An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years.Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects - an explorative cross-sectional study.Seroepidemiology of Toxoplasma in a coastal region of Haiti: multiplex bead assay detection of immunoglobulin G antibodies that recognize the SAG2A antigen.Toxoplasma gondii protects against H(2)O(2) -induced apoptosis in ARPE-19 cells through the transcriptional regulation of apoptotic elements and downregulation of the p38 MAPK pathway.Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.PCR-based Diagnosis of Toxoplasma Parasite in Ocular Infections Having Clinical Indications of Toxoplasmosis.Seroprevalence of Toxoplasma gondii in White-Tailed Deer (Odocoileus virginianus) and Free-Roaming Cats (Felis catus) Across a Suburban to Urban Gradient in Northeastern Ohio.Development of Dose-Response Models to Predict the Relationship for Human Toxoplasma gondii Infection Associated with Meat Consumption.Quantifying the Risk of Human Toxoplasma gondii Infection Due to Consumption of Domestically Produced Lamb in the United States.
P2860
Q21090649-9249DCE8-F3C1-4204-9939-6E45571D81C4Q21092273-17C14099-E4E4-4F2D-B798-1EF1BB48B552Q22305416-2FAE9161-AA9D-4F0F-A84C-5FDA122C7DD1Q30487158-C85365E3-FB26-4C90-BF98-192147C28A8CQ31111181-819322FC-A1F6-4BAC-A98F-374E88E42EDBQ33669275-33C6F5AE-BE42-4777-AF2C-1DC8424F19A2Q33719625-CE303689-51E8-45EA-8CAD-59360F3C31C2Q33774960-7D1BE47E-DF84-4428-B70C-0ABFF8EA8E3BQ33847266-FAE07057-D30C-496E-B643-0400FDCAD2B5Q34119416-CA3D52FD-BB28-4BB3-8BB9-73F38B946A62Q34276716-605D0D15-72C4-469F-BFFF-24102216243EQ34458916-32009B12-D5BE-413F-8774-CE5FC2EF2F67Q34636597-59DE0136-A61C-45D2-B596-8927CE5B82A9Q35183980-8A9C6A79-D171-42A6-A240-FAD030237D07Q35271230-4E54BC15-2B8C-4594-B343-285D0D1C3508Q35439431-D8103516-DBB4-4230-82FB-FDE17BFFF3D4Q35923873-8290AEEA-4717-4998-BB26-A9894A3B26C1Q36100114-98EA26BC-438F-488B-ABEE-F8E332D0DD36Q36107947-8D66922B-5537-4987-A7A0-73596CDE4A65Q36181586-D3B490B4-231C-4757-A02B-8E13170818B5Q36645185-DCE6AC33-EF35-4FD1-822B-4890E15A95F1Q36678773-5D38E54C-C0A7-4B73-8E32-C68906691233Q36883228-872367FD-8332-48F5-A955-1F67361412E6Q37287221-60735728-EAEF-4BD1-9D50-62549D8179BBQ37417245-69159452-719B-4D00-ADF1-645A48AE369DQ37613765-1EB4FDDB-E5A8-443C-A11C-9FF902CDFDEBQ38010807-3F0634CB-64C7-4B5B-A467-275D6B2C2926Q38024897-9A4C6800-BA15-415F-A7D9-63E2D1333537Q38044637-5E8DFACA-B5BE-4290-8C11-000C7C4962E9Q39021968-50D226A4-F87A-4BE3-8B0C-2CD047CA07ECQ39038453-61F61B4B-5E17-49FD-B1D8-4BCBC2A2731FQ39045924-4D8A33E5-E35A-46E1-B996-E72536B470FCQ39309629-B0C161F8-B3EA-40FD-B07E-25B5DB3380A1Q39369012-83EBC9D4-715E-4059-90CE-7D5012395490Q39579462-162EA7C7-B2F3-4531-8418-B54BA326C627Q40063101-DDC8E7A4-60D1-4C3A-AA0C-9DF73844271EQ40112232-05059447-175D-4DCC-BE63-362A3F25F375Q40225602-A53734FB-BA13-43EE-BA28-7C51AE59AF46Q40419016-BDC29EAC-F4DD-4263-8EDE-5878EC08EFFBQ40631654-AA84ABA1-F4F8-43C8-AA15-60965E7A9549
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Annual burden of ocular toxoplasmosis in the US.
@ast
Annual burden of ocular toxoplasmosis in the US.
@en
type
label
Annual burden of ocular toxoplasmosis in the US.
@ast
Annual burden of ocular toxoplasmosis in the US.
@en
prefLabel
Annual burden of ocular toxoplasmosis in the US.
@ast
Annual burden of ocular toxoplasmosis in the US.
@en
P2860
P1476
Annual burden of ocular toxoplasmosis in the US.
@en
P2093
Gary N Holland
Jeffrey L Jones
P2860
P304
P356
10.4269/AJTMH.2010.09-0664
P407
P577
2010-03-01T00:00:00Z